Healthcare entity
regulation is the sole category represented across all 1 tracked stories. Valion Bio, Inc. is most often covered alongside Entolimod, which appears in 1 of these 1 story. Each carries 2 original sources on average. We currently track 1 Healthcare story that mention Valion Bio, Inc., all published on August 13, 2026.
Last mentioned: Aug 13, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
regulation is the sole category represented across all 1 tracked stories. Valion Bio, Inc. is most often covered alongside Entolimod, which appears in 1 of these 1 story. Each carries 2 original sources on average. We currently track 1 Healthcare story that mention Valion Bio, Inc., all published on August 13, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 18 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Valion Bio, Inc.. Shared-story counts are live from our verified record — not editorial picks.
Valion Bio announces technical assessment underway
Valion Bio issued a press release stating the Ministry has begun technical assessment and issued a first round of questions on physicochemical characterization.
Ukraine MOH accepts Entolimod dossier
Ukraine's Ministry of Health accepted Valion Bio's regulatory dossier for Entolimod for formal review under the Regulatory Equivalence Pathway.
Ukraine's Ministry of Health has moved Valion Bio's Entolimod dossier into technical assessment, a step toward what would be the drug's first national registration as an acute radiation syndrome countermeasure. The company says a decision could come as early as Q4 2026, though no procurement or stockpiling agreement exists.
Source: hawaiitelegraph.com · finanznachrichten.de
Valion Bio, Inc. is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
